b12 injections with amino acids Vitamin 20 mL | Clinic-Ready, High Potency B12 Injections - Emediate Cure

Assuming that the percentage of patients showing an increase in serum vitamin B12 concentration to above 179 pg/ml in both groups is 70%, means the study requires at least 304 patients (152 in each arm) for a threshold of non-inferiority of 10% and a statistical power of 60% with significance set at p 179 pg/ml: patient preference questionnaire Randomisation of patients to treatment group Visit 1 (start of treatment) Anamnesis: record whether the patient lives alone or with others, lifestyle habits, use of alcohol, whether a vegan diet is followed, whether the patient has undergone gastrectomy Symptoms: record paresthesia, asthenia, loss or reduction of appetite, sadness or change in state of mind, concomitant pharmacological treatment Physical examination: for Hunters glositis, positional and vibrational sensitivity Questionnaires: Lobo cognitive mini-exam, EuroQoL-5D Record concomitant treatment Request analyses to be performed one week before next visit: haemogram and serum vitamin B12 Therapeutic plan: patient in oral arm provision of medication

Day 7 inject hyper B-12

Summary: B12 deficiency neurological symptoms include tingling, numbness, gait disturbances, memory problems, and in severe cases, spinal cord damage that may become irreversible without prompt treatment

+Shipping 5-Amino-1MQ 50mg Research Grade Peptide Availability: In stock Description 5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small molecule research compound that functions as a selective inhibitor of nicotinamide N-methyltransferase (NNMT)

The codes are differentiated between organ imaging and targeted lesion imaging

Manufacturing data shows that purity levels change by less than 0.1% between runs of production